Le Lézard
Classified in: Science and technology, Covid-19 virus
Subjects: SVY, CPN

Study.com Survey Says... Who's On Deck For Election Education? Students Say Teachers, Teachers Say Parents


MOUNTAIN VIEW, Calif., Oct. 15, 2020 /PRNewswire/ -- Who's teaching tomorrow's voters today? With the election just weeks away, a new survey about student, teacher and parent election knowledge from Study.com, shows little agreement about who is responsible for educating the country's students about the election process.

A snapshot of the Study.com survey findings reveals:

Students are learning the most about the election process from teachers:

But teachers are hesitant to take on a political influencer role in the classroom:

A disconnect between teacher and student expectations about voting preparation:

Voter preparation isn't being taught at home:

Study.com Survey Says is a monthly research project conducted by Study.com to provide regular snapshots of teachers, parents and students' perspectives on the world of learning.

Study.com surveyed 231 K-12 teachers, 201 K-12 students and 146 parents from October 1-5, 2020 to examine topical issues related to education, election knowledge and the COVID-19 Learning Cliff. For all of the findings from the study, visit https://study.com/blog/study-com-survey-says-election-knowledge.html.

About Study.com

Study.com is a leading online education platform helping learners of all ages excel academically and close skills gaps. Study.com's online courses, short animated video lessons, and study tools make learning simple for over 30 million students, teachers, and working professionals. Study.com was founded in 2002 and is a privately held company located in Mountain View, Calif. Learn more at https://www.study.com or download the mobile app from the iOS app store or Google Play.

 

SOURCE Study.com


These press releases may also interest you

at 06:00
BioInvent International (STO:BINV)Preliminary data presented at ESMO 2024 demonstrate BT-001 induces tumor regression in patients who failed previous anti-PD(L)-1 treatmentIn a patient with a heavily pretreated leiomyosarcoma, BT-001 was able to...

at 05:18
Mox Capital, a trailblazer in alternative investments with AUM of US$1.4 billion, is announcing its strategic support for a vast array and variety of regional high-potential startups. According to COO Nguyen Dinh Giang, Mox Capital seeks to reinforce...

at 05:00
Updated Phase 1 dose-escalation data from ARROS-1 and ALKOVE-1 clinical trials continue to support potential best-in-class profiles for zidesamtinib and NVL-655 Rapid enrollment in Phase 2 portions of the ARROS-1 and ALKOVE-1 clinical trials;...

at 04:20
Pfizer Inc. today announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy and safety of BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for patients with BRAF V600E-mutant...

at 04:06
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, announced the latest clinical data on...

at 04:05
Irdeto, the global leader in digital video platform experiences and security, and Bitmovin, the industry leader in video software solutions, today announced a strategic partnership to deliver enhanced secure video streaming experiences. This...



News published on and distributed by: